G01N 2333/5255
Lymphotoxin [lt]
Official title: Lymphotoxin [LT]
G01N2333/5255 (Lymphotoxin [lt]) appears on 3 US grants and 13 published applications in this corpus.
Search patents in G01N- Granted patents
- 3
- Published applications
- 13
- Assignees
- 8
- Inventors
- 32
- Latest grant
- 7 Mar 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 2 | 3 |
| 2022 | 0 | 2 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for analysis, detection, and treatment of multiple sclerosis22 Jan 2026US 2026/0023085 A1The Regents of the University of Michigan
- Methods of treating immunotherapy-associated adverse effects25 Sep 2025US 2025/0298034 A1Northwestern University
- Informative biomarkers of portal hypertension27 Mar 2025US 2025/0102521 A1
- Compositions and methods for reducing cytokine expression19 Jan 2023US 2023/0019986 A1Evelo Biosciences, Inc.
- Methods and products for treatment of gastrointestinal disorders18 Aug 2022US 2022/0257670 A1Finch Therapeutics Holdings LLC
Most cited
By later US patents